Pallas Health vs Maximus: Which GLP-1 Telehealth Fits You?
Quick verdict: Pallas Health is best if you want a clinician to choose between FDA-approved brand pens and compounded options in one program; Maximus is best if you want a low flat-rate compounded semaglutide plan with simple telemedicine access.
How Pallas Health vs Maximus compare at a glance
This comparison focuses on the key differences supported by source evidence: pricing structure, availability of brand-name versus compounded medications, telemedicine and visit requirements, what is included in plan pricing, and regulatory notes about compounded medications. The primary keyword Pallas Health vs Maximus appears early because readers search these platforms against each other.
Pricing and billing
Pallas Health lists compounded semaglutide at a starting price of $139 for the first month, then $597 every 12 weeks, which the provider presents as a $199 per month average. Compounded tirzepatide starts at $179 first month, then $897 every 12 weeks, a $299 per month average. Pallas also offers cash-pay brand-name Wegovy, Ozempic, Zepbound and Mounjaro at higher monthly cash prices. Maximus promotes a low flat rate of $132.99 per month for compounded semaglutide and highlights straightforward direct-pay billing with no insurance billing.
See Maximus pricing and sign up
Brand-name availability versus compounded-only
Pallas Health explicitly offers both FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide when a brand is not the right fit. Maximus, by contrast, is presented as a compounded-semiglutide offering only; the source notes Maximus does not offer branded Ozempic, Wegovy or Zepbound.
Compare brand and compounded options at Pallas Health
Telemedicine access, state rules, and visit requirements
Both platforms use online clinician review and telemedicine. Pallas positions itself as 100 percent online and asynchronous in most states, noting that 43 of 50 states need no video visit while a video visit is required in seven states plus Washington D.C. Maximus emphasizes convenient telemedicine access with no clinic visits and says its prescription approvals are handled by licensed doctors; Maximus notes availability in all 50 states except Mississippi for its Weight Loss Protocol.
What plan price includes and care model
Pallas states its plan price includes provider care, ongoing check-ins and care-team messaging with no membership fee and free expedited shipping. Pallas also notes self-serve portal features and a free companion app. Maximus highlights prescriptions approved by licensed doctors, medication filled through trusted U.S. pharmacies, and free priority shipping; it promotes a simple direct-pay model and transparent monthly pricing.
Regulatory and refund notes
Both sources include the regulatory caution that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Pallas notes it does not manufacture or compound medication and that compounded medications are prepared by U.S. compounding pharmacies and may differ in appearance from product images. Maximus says if you are not approved for treatment your medication costs will be fully refunded.
| Criteria | Pallas Health | Maximus |
|---|---|---|
| Starting price | $139 first month for compounded semaglutide ($199/mo avg) | $132.99 per month for compounded semaglutide |
| Brand-name GLP-1s | Offers FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro | No branded GLP-1s; compounded only |
| Telemedicine and visits | 100% online; asynchronous in most states; video visit required in 7 states plus D.C. | Telemedicine only; no clinic visits; available in all states except Mississippi |
| Plan includes | Provider care, check-ins, messaging, free expedited shipping, no membership fee | Doctor-approved prescriptions filled by U.S. pharmacies, free priority shipping, no membership fee |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
How these differences affect your choice
If price is the single deciding factor, Maximus advertises a lower flat rate at $132.99 per month for compounded semaglutide. If you want the option of an FDA-approved branded pen or a clinician to choose the right route for you, Pallas Health lets a U.S. licensed clinician pick between brand-name GLP-1s and compounded preparations within one intake.
Start Maximus telemedicine intake
Conclusion: Pallas Health vs Maximus
In a direct comparison Pallas Health vs Maximus, Pallas is designed for patients who want clinician flexibility between brand-name and compounded GLP-1s and a plan that includes provider care and messaging in the price. Maximus is positioned for patients seeking a straightforward, lower flat-rate compounded semaglutide program delivered via telemedicine.
Choose Pallas Health if you want a clinician to select between FDA-approved brand pens and U.S.-compounded GLP-1s, prefer plan pricing that includes provider care and check-ins, and accept cash-pay only terms. Choose Maximus if you prioritize the lowest advertised monthly flat rate for compounded semaglutide and want a simple telemedicine prescription filled through U.S. pharmacies.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →